1,4-Dichloropyrido[3,4-d]pyridazine

Catalog No.: 
ACLDRN183
CAS No.: 
14490-19-8
Molecular Formula: 
C7H3Cl2N3
Molecular Weight: 
200.03
1,4-Dichloropyrido[3,4-d]pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$87.00In stockIn stock
25g97%$430.00In stockIn stock
100g97%$1345.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,4-Dichloropyrido[3,4-d]pyridazine
IUPAC Name1,4-dichloropyrido[3,4-d]pyridazine
MDL No.MFCD09839782
Molecular FormulaC7H3Cl2N3
Molecular Weight200.03
SMILESClC1=NN=C(Cl)C2=CC=NC=C12
InChI KeyLMVNXZZDBBSCSG-UHFFFAOYSA-N
Synonym1,4-Dichloropyrido[4,3-d]pyridazine | 14490-19-8 | 1,4-dichloropyrido[3,4-d]pyridazine | Pyrido[3,4-d]pyridazine, 1,4-dichloro- | MFCD09839782 | 1,4-DICHLORO-PYRIDO[3,4-D]PYRIDAZINE | SCHEMBL793650 | DTXSID30481242 | LMVNXZZDBBSCSG-UHFFFAOYSA-N | AMY24919 | SC2941 | AKOS015850
CAS No.14490-19-8
PubChem CID12224497

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLDRN183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLDRN183 route product structure diagram
    ACLDRN18314490-19-8In Stock
Inquiry

2. ACLDRN183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLDRN183 route product structure diagram
    ACLDRN18314490-19-8In Stock
Inquiry

3. ACLDRN183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLDRN183 route product structure diagram
    ACLDRN18314490-19-8In Stock
Inquiry

Comments (0)